U.S Futures jump - Watch MRNA, PNC, SPG, TCO, JD, TLRY

,

The S&P 500 Futures are jumping after they returned to positive territory on Friday

Trading floor 2

The S&P 500 Futures are jumping after they returned to positive territory on Friday.

Later today, the New York Federal Reserve will publish November Empire Manufacturing Index (13.8 expected).

European indices have accelerated on the upside after Moderna announced its Covid-19 vaccine met a 94.5% efficacity during its Phase-3 study.

Asian indices ended on a strong advance. Earlier today, government data showed that China's industrial production grew 6.9% on year in October (+6.7% expected). Japan's 3Q annualized GDP rose 21.4% on quarter (+18.9% expected).

WTI Crude Oil is rebounding. The total number of rotary rigs in the U.S. rose to 312 as of November 13 from 300 in the prior week, and rigs in Canada increased to 89 from 86, according to Baker Hughes.

U.S indices closed up on Friday, lifted by Energy (+3.81%), Automobiles & Components (+3.57%) and Consumer Durables & Apparel (+2.36%) sectors.

Approximately 82% of stocks in the S&P 500 Index were trading above their 200-day moving average and 80% were trading above their 20-day moving average. The VIX Index dropped 2.22pts (-8.76%) to 23.13, while Gold gained $11.13 (+0.59%) to $1887.95, and WTI Crude Oil fell $1.01 (-2.46%) to $40.11 at the close.

On the US economic data front, the Producer Price Index Final Demand rose 0.3% on month in October (+0.2% expected), compared to +0.4% in September. Finally, the University of Michigan's Consumer Sentiment Index unexpectedly fell to 77.0 on month in the November preliminary reading (82.0 expected), from 81.8 in the October final reading.

Gold rose 3.42 dollars (+0.18%) to 1892.63 on easing U.S dollar as U.S coronavirus cases continue to climb.

The dollar index fell 0.09pt to 92.668

EUR/USD rose 6pips to 1.184 while GBP/USD gained 13pips to 1.3202 on hopes for compromize regarding Brexit talks.


U.S. Equity Snapshot


Moderna (MRNA), the biotech, jumps premarket after announcing "that the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%." 


Source: TradingView, GAIN Capital

PNC Financial Services Group (PNC), a bank holding company, has agreed to acquire Spanish bank BBVA's U.S. business BBVA USA Bancshares for a purchase price of 11.6 billion dollars.

Simon Property Group (SPG), a commercial real estate company, agreed to pay 43.00 dollars per share to acquire Taubman Centers (TCO), down from 52.20 dollars per share originally.

JD.com (JD), the chinese e-commerce company, reporting better than expected quarterly sales up 29% to 26.5 billion dollars.

Tilray (TLRY), the pharmaceutical company, was downgraded to "underperform" from "hold" at Jefferies.

More from Equities

Disclaimer

This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.

Important Notice:

Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.